News & Updates
Filter by Specialty:
Antidepressant therapy: To continue or not?
In individuals who had been on antidepressant therapy for at least 9 months but felt well enough to consider discontinuing, the risk of relapse of depression was greater among those who stopped vs those who carried on with their current regimen, the ANTLER* trial has shown.
Antidepressant therapy: To continue or not?
14 Dec 2021
Can losartan delay the progression of AD?
In individuals with clinically diagnosed mild-to-moderate Alzheimer’s disease (AD), treatment with the angiotensin II receptor blocker (ARB) losartan for 12 months did not reduce the rate of brain atrophy, findings from the phase II RADAR* trial suggest.
Can losartan delay the progression of AD?
13 Dec 2021
Low-dose aspirin does not stave off dementia
A daily 100 mg dose of aspirin for 7 years did not reduce the risk of dementia in individuals with diabetes and no history of cardiovascular disease (CVD), according to results of the ASCEND* study presented at AHA 2021.
Low-dose aspirin does not stave off dementia
10 Dec 2021
Wearables capture patterns of activity, gait, tremors in Parkinson’s disease patients
Parkinson’s disease (PD) significantly impairs activity even when patients are in their natural environment, according to a recent real-world study.
Wearables capture patterns of activity, gait, tremors in Parkinson’s disease patients
10 Dec 2021
Cholinesterase inhibitors show promise for treating gait disturbance in PD
Treatment with cholinesterase inhibitors in patients with Parkinson’s disease (PD) leads to significant improvements in gait variability, with trending benefits for gait speed and fall prevention, according to the results of a meta-analysis.
